Anticardiolipin and anti-beta2 glycoprotein I antibodies in infants born to mothers with antiphospholipid antibody-positive autoimmune disease: a follow-up study.

Infants born from mothers with antiphospholipid antibody (aPL) -positive autoimmune disease were prospectively evaluated for anticardiolipin and anti-beta2 glycoprotein I antibodies (group 1) and for growth and neurological development. The results were compared with those obtained from two age-matched control groups (group 2 and 3). All infants were negative for anticardiolipin at 12 months of life, whereas 14 (63.6%), eight (33.3%), and 10 (55.5%) of infants from group 1, 2, and 3, respectively, were positive for anti-beta2 glycoprotein I. At follow-up, all infants had normal growth and neurological development. No thrombotic complication was observed. The negativity of anticardiolipin in all infants at 12 months suggests that anticardiolipin detection is the best assay to evaluate the disappearance of maternal aPL and to estimate the potential risk of thrombosis associated with these antibodies. The high rate of anti-beta2 glycoprotein I positivity in all three groups of infants may indicate that the synthesis of this antibody is stimulated by aspecific factors.

[1]  Y. Shoenfeld,et al.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) , 2006, Journal of thrombosis and haemostasis : JTH.

[2]  J. Piette,et al.  Prevalence and Clinical Correlations of Antibodies Against Six β2-Glycoprotein-I-Related Peptides in the Antiphospholipid Syndrome , 2003, Journal of Clinical Immunology.

[3]  M. Khamashta,et al.  Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. , 2003, Obstetrics and gynecology.

[4]  A. Tincani,et al.  Pregnancy and neonatal outcome in primary antiphospholipid syndrome , 2002, Lupus.

[5]  R. Cimaz,et al.  Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations , 2002, Lupus.

[6]  T. Koike,et al.  Anticardiolipin Antibody Assay: a Methodological Analysis for a better Consensus in Routine Determinations , 2001, Thrombosis and Haemostasis.

[7]  T. Kveder,et al.  Anticardiolipin and anti-beta(2) glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits. , 2001, Rheumatology.

[8]  L. Carreras,et al.  Which are the best biological markers of the antiphospholipid syndrome? , 2000, Journal of autoimmunity.

[9]  B. Gilburd,et al.  Anti-cardiolipin antibodies in fetal blood and amniotic fluid derived from patients with the anti-phospholipid syndrome. , 2000, Human reproduction.

[10]  W A Wilson,et al.  International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. , 1999, Arthritis and rheumatism.

[11]  T. Barbui,et al.  Antiprothrombin antibodies: detection and clinical significance in the antiphospholipid syndrome. , 1999, Blood.

[12]  T. del Ross,et al.  Outcome of fifty-five newborns of antiphospholipid antibody-positive mothers treated with calcium heparin during pregnancy. , 1998, Clinical and experimental rheumatology.

[13]  N. Cohen-Addad,et al.  Neonatal middle cerebral artery infarction: association with elevated maternal anticardiolipin antibodies. , 1998, American journal of perinatology.

[14]  T. D. de Vries,et al.  An unusual cause of neonatal seizures in a newborn infant. , 1997, Pediatrics.

[15]  F. Navarro,et al.  Neonatal antiphospholipid syndrome. , 1997, The Journal of rheumatology.

[16]  D. Alarcón-Segovia,et al.  The antiphospholipid/cofactor syndromes: a primary variant with antibodies to beta 2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays. , 1996, The American journal of medicine.

[17]  V. Gautheron,et al.  Anticorps anticardiolipine, ischémie cérébrale et hémorragie surrénalienne chez un nouveau-né , 1995 .

[18]  A. Tincani,et al.  Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome? , 1995, Lupus.

[19]  J. Bowie,et al.  Fetal renal vein thrombosis, hydrops fetalis, and maternal lupus anticoagulant. A case report , 1994, Prenatal diagnosis.

[20]  Y. Shoenfeld,et al.  Detection of Anti-Phospholipid and Anti-DNA Antibodies and their Idiotypes in Newborns of Mothers with Anti-Phospholipid Syndrome and SLE , 1993, Lupus.

[21]  J. Pollard,et al.  Outcome of Children Born to Women Treated During Pregnancy for the Antiphospholipid Syndrome , 1992, Obstetrics and gynecology.

[22]  M. Hiatt,et al.  Neonatal Thrombosis with Anticardiolipin Antibody in Baby and Mother , 1992, American journal of perinatology.

[23]  R. Silver,et al.  FETAL STROKE ASSOCIATED WITH ELEVATED MATERNAL ANTICARDIOLIPIN ANTIBODIES , 1992, Obstetrics and gynecology.

[24]  Z. Amoura,et al.  Association of anti-β2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus☆ , 1992 .

[25]  T. Koike,et al.  Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease , 1990, The Lancet.

[26]  T. Barbui,et al.  Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor , 1990, The Lancet.

[27]  C. Chesterman,et al.  Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Sheridan-Pereira,et al.  NEONATAL AORTIC THROMBOSIS ASSOCIATED WITH THE LUPUS ANTICOAGULANT , 1988, Obstetrics and gynecology.

[29]  T. Barbui,et al.  Maternal Lupus Anticoagulant and Fatal Neonatal Thrombosis , 1987, Thrombosis and Haemostasis.

[30]  G. Hughes,et al.  The anticardiolipin syndrome. , 1985, The Journal of rheumatology.

[31]  M. C. Pangborn.  A New Serologically Active Phospholipid from Beef Heart , 1941 .

[32]  P. Casali,et al.  Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. , 2000, Arthritis and rheumatism.

[33]  N. Shaw,et al.  Neonatal and pediatric outcome of infants born to mothers with Antiphospholipid Syndrome , 1999, Journal of perinatal medicine.

[34]  Francesc Botet,et al.  Neonatal outcome in women treated for the antiphospholipid syndrome during pregnancy , 1997, Journal of perinatal medicine.

[35]  S. Tabbutt,et al.  Multiple thromboses in a premature infant associated with maternal phospholipid antibody syndrome. , 1994, Journal of perinatology : official journal of the California Perinatal Association.